(firstQuint)Patient Insights Following Use of LEO 90100 Aerosol Foam and Daivobet Gel in Subjects With Psoriasis Vulgaris.

 An international, multi-centre, prospective, open-label, randomised, 2-arm, cross-over study with 14-days once daily treatment in subjects with psoriasis vulgaris.

 To gather insight on how product attributes affect usability by investigating the factors that are thought to influence patient preference to topical anti-psoriatic treatments.

.

 Patient Insights Following Use of LEO 90100 Aerosol Foam and Daivobet Gel in Subjects With Psoriasis Vulgaris@highlight

To gather insight on how product attributes affect usability by investigating the factors that are thought to influence patient preference to topical anti-psoriatic treatments.

